New Roles for Old Friends: Involvement of the Innate Immune System in Tumor Progression
Author Contributions
Institutional Review Board Statement
Informed Consent Statement
Conflicts of Interest
References
- Kaur, B.P.; Secord, E. Innate Immunity. Immunol. Allergy Clin. N. Am. 2021, 41, 535–541. [Google Scholar] [CrossRef] [PubMed]
- Gajewski, T.F.; Schreiber, H.; Fu, Y.-X. Innate and Adaptive Immune Cells in the Tumor Microenvironment. Nat. Immunol. 2013, 14, 1014–1022. [Google Scholar] [CrossRef] [PubMed]
- Bagchi, S.; Yuan, R.; Engleman, E.G. Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance. Annu. Rev. Pathol. Mech. Dis. 2021, 16, 223–249. [Google Scholar] [CrossRef] [PubMed]
- Chang, C.-Y.; Park, H.; Malone, D.C.; Wang, C.-Y.; Wilson, D.L.; Yeh, Y.-M.; Van Boemmel-Wegmann, S.; Lo-Ciganic, W.-H. Immune Checkpoint Inhibitors and Immune-Related Adverse Events in Patients with Advanced Melanoma: A Systematic Review and Network Meta-Analysis. JAMA Netw. Open 2020, 3, e201611. [Google Scholar] [CrossRef]
- Tommasi, C.; Pellegrino, B.; Diana, A.; Palafox Sancez, M.; Orditura, M.; Scartozzi, M.; Musolino, A.; Solinas, C. The Innate Immune Microenvironment in Metastatic Breast Cancer. J. Clin. Med. 2022, 11, 5986. [Google Scholar] [CrossRef]
- Maiorano, B.A.; Maiorano, M.F.P.; Lorusso, D.; Maiello, E. Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives. Cancers 2021, 13, 4438. [Google Scholar] [CrossRef]
- Cui, K.; Hu, S.; Mei, X.; Cheng, M. Innate Immune Cells in the Esophageal Tumor Microenvironment. Front. Immunol. 2021, 12, 654731. [Google Scholar] [CrossRef]
- Gianni, C.; Palleschi, M.; Schepisi, G.; Casadei, C.; Bleve, S.; Merloni, F.; Sirico, M.; Sarti, S.; Cecconetto, L.; Di Menna, G.; et al. Circulating Inflammatory Cells in Patients with Metastatic Breast Cancer: Implications for Treatment. Front. Oncol. 2022, 12, 882896. [Google Scholar] [CrossRef]
- Rakic, A.; Beaudry, P.; Mahoney, D.J. The Complex Interplay between Neutrophils and Cancer. Cell Tissue Res. 2018, 371, 517–529. [Google Scholar] [CrossRef]
- Gonzalez, H.; Hagerling, C.; Werb, Z. Roles of the Immune System in Cancer: From Tumor Initiation to Metastatic Progression. Genes Dev. 2018, 32, 1267–1284. [Google Scholar] [CrossRef]
- Brinkmann, V.; Reichard, U.; Goosmann, C.; Fauler, B.; Uhlemann, Y.; Weiss, D.S.; Weinrauch, Y.; Zychlinsky, A. Neutrophil Extracellular Traps Kill Bacteria. Science 2004, 303, 1532–1535. [Google Scholar] [CrossRef] [PubMed]
- Masucci, M.T.; Minopoli, M.; Del Vecchio, S.; Carriero, M.V. The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis. Front. Immunol. 2020, 11, 1749. [Google Scholar] [CrossRef] [PubMed]
- Mauracher, L.-M.; Posch, F.; Martinod, K.; Grilz, E.; Däullary, T.; Hell, L.; Brostjan, C.; Zielinski, C.; Ay, C.; Wagner, D.D.; et al. Citrullinated Histone H3, a Biomarker of Neutrophil Extracellular Trap Formation, Predicts the Risk of Venous Thromboembolism in Cancer Patients. J. Thromb. Haemost. 2018, 16, 508–518. [Google Scholar] [CrossRef] [PubMed]
- Oto, J.; Navarro, S.; Larsen, A.C.; Solmoirago, M.J.; Plana, E.; Hervás, D.; Fernández-Pardo, Á.; España, F.; Kristensen, S.R.; Thorlacius-Ussing, O.; et al. MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma. Int. J. Mol. Sci. 2020, 21, 840. [Google Scholar] [CrossRef]
- Oto, J.; Plana, E.; Solmoirago, M.J.; Fernández-Pardo, Á.; Hervás, D.; Cana, F.; España, F.; Artoni, A.; Bucciarelli, P.; Carrabba, G.; et al. MicroRNAs and Markers of Neutrophil Activation as Predictors of Early Incidental Post-Surgical Pulmonary Embolism in Patients with Intracranial Tumors. Cancers 2020, 12, 1536. [Google Scholar] [CrossRef]
- Tomás-Pérez, S.; Oto, J.; Aghababyan, C.; Herranz, R.; Cuadros-Lozano, A.; González-Cantó, E.; Mc Cormack, B.; Arrés, J.; Castaño, M.; Cana, F.; et al. Increased Levels of NETosis Biomarkers in High-Grade Serous Ovarian Cancer Patients’ Biofluids: Potential Role in Disease Diagnosis and Management. Front. Immunol. 2023, 14, 1111344. [Google Scholar] [CrossRef]
- Strakhova, R.; Cadassou, O.; Cros-Perrial, E.; Jordheim, L.P. Regulation of Tumor Infiltrated Innate Immune Cells by Adenosine. Purinergic Signal. 2020, 16, 289–295. [Google Scholar] [CrossRef]
- Mamtimin, M.; Pinarci, A.; Han, C.; Braun, A.; Anders, H.-J.; Gudermann, T.; Mammadova-Bach, E. Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies. Front. Oncol. 2022, 12, 869706. [Google Scholar] [CrossRef]
- Xu, S.-S.; Li, H.; Li, T.-J.; Li, S.; Xia, H.-Y.; Long, J.; Wu, C.-T.; Wang, W.-Q.; Zhang, W.-H.; Gao, H.-L.; et al. Neutrophil Extracellular Traps and Macrophage Extracellular Traps Predict Postoperative Recurrence in Resectable Nonfunctional Pancreatic Neuroendocrine Tumors. Front. Immunol. 2021, 12, 577517. [Google Scholar] [CrossRef]
- Tcyganov, E.; Mastio, J.; Chen, E.; Gabrilovich, D.I. Plasticity of Myeloid-Derived Suppressor Cells in Cancer. Curr. Opin. Immunol. 2018, 51, 76–82. [Google Scholar] [CrossRef]
- Wu, S.-Y.; Fu, T.; Jiang, Y.-Z.; Shao, Z.-M. Natural Killer Cells in Cancer Biology and Therapy. Mol. Cancer 2020, 19, 120. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Castaño, M.; González-Cantó, E.; Aghababyan, C.; Tomás-Pérez, S.; Oto, J.; Herranz, R.; Medina, P.; Götte, M.; Mc Cormack, B.A.; Marí-Alexandre, J.; et al. New Roles for Old Friends: Involvement of the Innate Immune System in Tumor Progression. Int. J. Mol. Sci. 2023, 24, 7604. https://doi.org/10.3390/ijms24087604
Castaño M, González-Cantó E, Aghababyan C, Tomás-Pérez S, Oto J, Herranz R, Medina P, Götte M, Mc Cormack BA, Marí-Alexandre J, et al. New Roles for Old Friends: Involvement of the Innate Immune System in Tumor Progression. International Journal of Molecular Sciences. 2023; 24(8):7604. https://doi.org/10.3390/ijms24087604
Chicago/Turabian StyleCastaño, María, Eva González-Cantó, Cristina Aghababyan, Sarai Tomás-Pérez, Julia Oto, Raquel Herranz, Pilar Medina, Martin Götte, Bárbara Andrea Mc Cormack, Josep Marí-Alexandre, and et al. 2023. "New Roles for Old Friends: Involvement of the Innate Immune System in Tumor Progression" International Journal of Molecular Sciences 24, no. 8: 7604. https://doi.org/10.3390/ijms24087604